Embryoman
Researchers in a 2023 study combined the results of 74 studies to investigate what factors contribute to euploid live birth and miscarriage rates, identifying embryo quality, maternal age, specific diagnoses, repeat freeze/thaw, and other factors.
Researchers in a 2023 study used a procedure called “rescue in vitro maturation” to culture immature eggs collected after retrieval overnight, and found that a high proportion became mature and had comparable fertilization to sibling mature eggs, with many going on to form euploids.
Researchers in a 2023 study found decreased adverse pregnancy and neonatal outcomes in those who performed a natural vs medicated FET, including abnormal birth weights, preeclampsia, preterm births, and more.
Researchers in a 2023 study share the results of a survey that evaluates the use and attitude of natural cycle FETs in US clinics, which some studies have recently shown can lead to improved pregnancy outcomes compared to medicated FETs.
Researchers in a 2023 study evaluated factors affecting pregnancy outcomes after euploid transfer, and found that double euploid transfer, BMI, type of FET protocol, and the day of embryo biopsy all had an impact.
Researchers in their 2022 Cochrane review, performed a meta-analysis and combined the results of 32 studies that compared pregnancy outcomes of blastocyst and cleavage stage embryos, and found that blastocysts tend to produce better outcomes.
Researchers in a 2023 study discovered 6 genes associated with recurrent miscarriage of euploid embryos, which were found to impair reproductive ability in mouse models.
Researchers in a 2023 study found comparable pregnancy and neonatal outcomes when transferring a day 5 poor quality or a day 6 good quality embryo.